Syringe Production
Sector | Healthcare & Pharma
Syringes are essential to all vaccination, treatment, and diagnostic protocols. Yet, local production in Syria is minimal. This project establishes a modern syringe manufacturing facility to meet national demand and supply regional markets, including auto-disable, insulin, and standard-use syringes.

Capital Requirement

$8–12 million

Breakeven

Download Details

Dr. Haytham Albizem, MD, FACC, FACP
President – Strategic Investment Group
📧 admin@sig.international
📱 +1 (267) 252-6408
📍 Philadelphia, PA | Damascus, Syria